Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Liver Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Colon Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Liver Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

More Details View Practice Page

Pages